Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
More articles/Ad
More articles/Ad
More articles
-
A group of Suriname’s bondholders said they plan to support the government’s bid for a temporary debt standstill after the sovereign amended a consent solicitation to incorporate some of their requests. -
Hertz is returning to the ABS market for the first time since it filed for bankruptcy in March. The rental car company is revving up for a $4bn delayed draw securitization, a stepping stone towards longer-term ABS deals it hopes to issue next year, sources said.
-
Jacobio Pharmaceuticals is preparing to launch the roadshow for its Hong Kong IPO after winning approval to list from the city’ stock exchange last week.
-
China's Harbour Biomed, a clinical-stage biopharmaceutical company, has hit the road for its up to HK$1.8bn ($230.4m) listing.
-
Having entered default on Thursday, November 26 as the 30-day grace period on a missed coupon payment expired, Suriname has improved the terms on a consent solicitation that — if accepted by at least three quarters of bondholders — would allow it to escape the default and buy time for a more comprehensive debt restructuring.
-
JD Health International is set to close the international investor book for its up-to HK$27bn ($3.5bn) IPO a day early, according to a source familiar with matter.
